InterventionsHuman trial

Efficacy and Safety of Semaglutide 7.2 mg in Obesity and Type 2 Diabetes—STEP UP T2D Trial

ADA Scientific Sessions 2025 Abstract

The paper

LINGVAY I, BERGENHEIM SJ, BUSE JB et al.

ADA Scientific Sessions 2025 Abstract · 13 Jun 2025

Presented at ADA Scientific Sessions 2025 · Late-breaking 1978-LB

doi.org/10.2337/db25-1978-lb